Almost everyone arriving at a cancer diagnosis ends up holding a bottle of something. A friend brings turmeric. A cousin sends an article about vitamin C. Someone in a Facebook group swears by green tea extract. It is one of the few things that feels like doing something, at a point when most of what happens is being done to you.
It is worth knowing what the evidence actually says — including where it is weaker than the headlines suggest.
The short version
Every major body advises caution about supplements during active chemotherapy or radiation. The American Cancer Society puts it directly: “Many cancer experts advise people to avoid dietary supplements while getting cancer treatment,” and “antioxidants, such as vitamins C and E, might make some chemotherapy medicines less effective.”
The World Cancer Research Fund is blunter: “Unless specifically advised by an appropriately trained professional, the evidence does not support the use of supplements as a means of improving survival.”
That is the guidance. Now the interesting part — why the guidance is worded so carefully.
The study everyone cites, read properly
The strongest evidence on antioxidants during chemotherapy comes from a study embedded inside a real clinical trial. Researchers followed 1,134 patients with breast cancer enrolled in SWOG S0221 — a cooperative-group chemotherapy trial — who completed supplement questionnaires both before and during treatment. It was published in the Journal of Clinical Oncology in 2020.
Patients who used antioxidant supplements — vitamins A, C and E, carotenoids, coenzyme Q10 — both before and during treatment had a higher hazard of recurrence: adjusted hazard ratio 1.41, and a hazard ratio of 1.40 for death.
Here is the part usually left out. Neither result was statistically significant. The recurrence finding had a P value of .06 and a confidence interval of 0.98 to 2.04 — meaning the range of plausible true values includes “no effect at all.” The mortality finding had a P value of .14.
You will find this study reported as proof that antioxidants are dangerous during chemotherapy. That is not what it showed. What it showed is a signal pointing toward harm, in the largest prospective dataset anyone has, that did not reach the conventional threshold for significance.
So why does everyone advise against them anyway?
Because a signal plus a mechanism is enough to be careful with, when the downside is a cancer recurrence.
Several chemotherapy drugs and radiation work partly by generating oxidative stress inside cancer cells. Flooding the system with antioxidants during that window could plausibly blunt the effect. It is a coherent mechanism, and combined with an observational signal pointing the same direction, “let us not, during treatment” is a reasonable position — even without proof.
That is an honest reason to be cautious. It is a different reason than “studies prove antioxidants cause recurrence,” and we would rather give you the real one.
The interactions that are not ambiguous
Some are not signals. They are documented pharmacology, and the National Cancer Institute’s summary on therapy interactions lists them:
- St. John’s wort lowers blood levels of irinotecan, imatinib and docetaxel. This one is human data: in pharmacokinetic studies St. John’s wort reduced active irinotecan metabolite levels by about 42%, imatinib exposure by about 32%, and docetaxel exposure by about 12%. It is a potent inducer of the enzymes that clear those drugs, and less drug in your blood means less drug doing its job.
- Green tea polyphenols block the anticancer effect of bortezomib in laboratory work. NCI describes an in-vitro study in myeloma and glioblastoma cell lines plus a mouse xenograft model. Being precise about the level of evidence: this is preclinical, not a demonstrated human interaction. But the mechanism is specific and the drug is used in myeloma, so if you are on bortezomib, green tea extract is worth raising with your oncologist rather than assuming it is fine.
- High-dose beta-carotene increases lung cancer risk in current and former smokers. The World Cancer Research Fund grades this as convincing evidence.
The first and third are settled. The second is a laboratory finding worth respecting rather than a proven human interaction — and saying which is which is the whole point.
What about high-dose IV vitamin C?
Different question, because the route changes the pharmacology.
The National Cancer Institute’s summary, updated May 2025, states that “the FDA has not approved the use of high-dose vitamin C as a treatment for cancer.” It also notes it has been generally well tolerated in clinical trials, and that intravenous dosing reaches plasma concentrations oral dosing cannot — which is the pharmacological argument for the IV route in the first place.
The honest state of play: some human trials show improved quality of life and reduced chemotherapy toxicity when IV vitamin C is added to standard treatment; others show no clinical benefit, including a 2024 trial that found no improvement when it was added to docetaxel in prostate cancer. The mechanism is plausible, tolerability is good, and the efficacy question in humans is unresolved.
Anyone telling you more than that is ahead of the evidence.
What to actually do
Bring every bottle to your oncologist. Not a list from memory — the actual bottles, so someone can read the labels. This includes anything herbal, anything a naturopath or chiropractor recommended, anything from a friend, and anything you would describe as “just a vitamin.”
Ask specifically about your regimen. “Is there anything here that interacts with what I am on?” is a question your oncology pharmacist can answer well, and oncology pharmacists are one of the most underused resources in the building.
Treat food differently from supplements. None of this is an argument against eating well. Green tea as a drink is not green tea extract at supplement doses. A plant-forward diet is what the ACS survivor guideline recommends.
If something is genuinely deficient, that is a different conversation. Correcting a documented deficiency is not the same as taking antioxidants prophylactically during chemotherapy. That is what labs are for.
This article is educational and is not medical advice. Talk to your oncology team before starting or stopping any supplement. Venturis Clinic is not a cancer treatment center and does not treat cancer.
Written by Dr. Alvin Philipose, B.S., B.S., DC, ICCP
Reviewed 20 August 2026
